The Vitiligo Working Group recommendations for narrowband ultraviolet B light phototherapy treatment of vitiligo - 18/04/17
, John E. Harris, MD, PhD c, Giovanni Leone, MD d, Raúl Cabrera, MD e, Henry W. Lim, MD a, Amit G. Pandya, MD f, Samia M. Esmat, MD gAbstract |
Background |
Treatment of vitiligo with narrowband ultraviolet B light (NBUVB) is an important component of the current standard of care. However, there are no consistent guidelines regarding the dosing and administration of NBUVB in vitiligo, reflected by varied treatment practices around the world.
Objective |
To create phototherapy recommendations to facilitate clinical management and identify areas requiring future research.
Methods |
The Vitiligo Working Group (VWG) Phototherapy Committee addressed 19 questions regarding the administration of phototherapy over 3 conference calls. Members of the Photomedicine Society and a group of phototherapy experts were surveyed regarding their phototherapy practices.
Results |
Based on comparison and analysis of survey results, expert opinion, and discussion held during conference calls, expert recommendations for the administration of NBUVB phototherapy in vitiligo were created.
Limitations |
There were several areas that required further research before final recommendations could be made. In addition, no standardized methodology was used during literature review and to assess the strength of evidence during the development of these recommendations.
Conclusion |
This set of expert recommendations by the VWG is based on the prescribing practices of phototherapy experts from around the world to create a unified, broadly applicable set of recommendations on the use of NBUVB in vitiligo.
Le texte complet de cet article est disponible en PDF.Key words : expert recommendation, narrowband phototherapy, pigmentation, UVB, vitiligo
Plan
| Funding sources: None. |
|
| Dr Mohammad is a subinvestigator for Allergan, Ferndale Laboratories, and Estee Lauder. Dr Hamzavi is an investigator for Clinuvel, Estee Lauder, Allergan, Ferndale Laboratories, and Johnson and Johnson, and has received equipment from Johnson and Johnson. Dr Lim is a consultant for L'Oreal, Pierre Fabre, and Mitsubishi Tanabe, and an investigator for Estee Lauder, Ferndale, and Allergan. Drs Leone, Pandya, Al Jamal, Harris, Cabrera, and Esmat have no conflicts of interest to declare. |
|
| Presented at PigmentaryCon 2016, April 2, 2016, Delhi, India. |
|
| Drs Mohammad and Al-Jamal contributed equally to this article. |
Vol 76 - N° 5
P. 879-888 - mai 2017 Retour au numéro
Article précédent
- Vitiligo and overt thyroid diseases: A nationwide population-based study in Korea
- Jung Min Bae, June Hyunkyung Lee, Jae Seung Yun, Byeol Han, Tae Young Han
- Prospective studies on the routine use of a novel multivariant enzyme-linked immunosorbent assay for the diagnosis of autoimmune bullous diseases
- Nina van Beek, Cornelia Dähnrich, Nora Johannsen, Susanne Lemcke, Stephanie Goletz, Franziska Hübner, Giovanni Di Zenzo, Marian Dmochowski, Kossara Drenovska, Shamir Geller, Michael Horn, Cezary Kowalewski, Ljiljana Medenica, Dedee F. Murrell, Aikaterini Patsatsi, Soner Uzun, Snejina Vassileva, Detlef Zillikens, Wolfgang Schlumberger, Enno Schmidt
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?